MADRIGAL PHARMACEUTICALS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+20.9% +$217M
$1.26B
Current Assets↑+20.6% +$213M
$1.25B
Cash & Equivalents↑+98.7% +$99M
$199M
ST Investments
—
Receivables↑+149.9% +$81M
$134M
Inventory↑+119.7% +$41M
$75M
Net PPE↓-31.6% -$691K
$1M
Intangibles↑+56.1% +$3M
$7M
Total Liabilities↑+128.2% +$369M
$657M
Current Liabilities↑+83.3% +$141M
$310M
Account Payables↑+12.1% +$5M
$49M
Long-Term Debt↑+189.1% +$222M
$340M
Stockholders Equity↓-20.1% -$152M
$603M
Retained Earnings↓-16.0% -$288M
$-2.09B
Operating Lease ROU Asset↑+105.7% +$3M
$5M
Operating Lease Liability↑+661.2% +$7M
$8M
Gross PP&E
—
Accumulated Depreciation
—
Inventory Raw Materials
$0
Inventory WIP↑+129.0% +$38M
$68M
Inventory Finished Goods↑+58.9% +$3M
$7M